Delivery Order SPE2DB20D2001-SPE2DB24FM79G

Award Date 8/9/24
Potential Completion Date 8/12/24
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Repatha, a specialty medication used to treat cardiovascular conditions. The contract has a ceiling value of $4,174.14 and an ultimate completion date of August 2, 2023. This contract is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Repatha, a prescription medication, at a firm fixed price of $1,735.70. The contract has an ultimate completion date of May 2, 2025 and was awarded on May 1, 2025. This contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of the pharmaceutical product Repatha (140 mg/mL SureClick) at a ceiling value of $2,033.64. The contract has a firm fixed price and an ultimate completion date of October 22, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of Repatha, a specialty medication used to treat cardiovascular conditions. The contract has a ceiling value of $1,331.22 and a period of performance through May 15, 2024. It is a firm fixed-price Delivery Order contract and was not set aside for any specific business type. The contract is likely part of a larger Indefinite Delivery...
This is a delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,742.10 firm fixed-price contract is for the supply of Repatha 140 mg/mL SureClick medication. The contract has a completion date of July 10, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Repatha, a specialty medication for cardiovascular health, at a firm fixed price of $1,263.48. The award is not designated as a set-aside contract. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication Repatha (140 mg/mL SureClick). The contract has a firm fixed price of $1,041.42 and a period of performance through May 2, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Repatha, a 140 mg/mL SureClick medication, with a ceiling value of $1,659.59 and a period of performance through April 24, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with the DLA Troop Support Medical, valued at $999,999,999.00...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Repatha, a 140 mg/mL SureClick medication, with a ceiling value of $6,348.60 and a performance period ending on May 1, 2025. The contract is a firm fixed-price delivery order, and it is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Repatha, a specialty medication used to treat cardiovascular conditions, with a ceiling value of $4,687.38. The contract has a firm fixed price pricing type and an ultimate completion date of December 5, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract...
  • SPE2DB20D2001
    Indefinite Delivery Contract
  • SPE2DB20D2001-SPE2DB24FM79G
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Repatha, a specialty medication used to treat cardiovascular conditions, with a ceiling value of $1,845.45. It is a firm-fixed-price contract with an ultimate completion date of August 12, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. There is no set-aside designation mentioned for this specific delivery order.

Generated 2/27/25, 1:16 PM